9:00am - 5:00pm

Our Opening Hours Mon. - Fri.

1.800.799.2234

Call Us For Free Consultation

Facebook

Twitter

Search
 

Intracavitary Cisplatin-Fibrin Localized Chemotherapy After P/D or EPP for Malignant Pleural Mesothelioma

Top West Virginia Mesothelioma Lawyer | Law Firm | Attorney | GPW > Intracavitary Cisplatin-Fibrin Localized Chemotherapy After P/D or EPP for Malignant Pleural Mesothelioma

Intracavitary Cisplatin-Fibrin Localized Chemotherapy After P/D or EPP for Malignant Pleural Mesothelioma

Estimated reading time: < 1 min

Condition: Malignant Pleural Mesothelioma

Estimated Enrollment: 54

Gender: All

Min Age: 18 Years

Age Group: Adult, Older Adult

Current Status: Recruiting

Study Results: No Results Available

Outcome Measures: Incidence of Treatment-Emergent Adverse Events (Safety),  Cisplatin concentration in the superficial chest wall tissue,  overall survival, FFR (= Freedom From Recurrence)

Interventions: intracavitary cisplatin-fibrin,

Phase:

Study Type: Interventional

Study Design: Intervention Model: Single Group Assignment, Masking: None (Open Label), Primary Purpose: Treatment,

Primary Completion Date: August 2020

Completion Date: August 2020

Last  Posted Date: August 24, 2017

Location: University Hospital Zurich, Division of Thoracic Surgery, Zurich, ZH, Switzerland

Website Link: https://ClinicalTrials.gov/show/NCT01644994

Was this article helpful?
Dislike 0